Understanding how certain genetic elements affect acute myeloid leukemia
Elucidating the Functional and Mechanistic Roles of LINE-1 Retrotransposons in Myeloid Leukemia
This study is looking at how certain genetic elements called LINE-1 retrotransposons might play a role in the development of acute myeloid leukemia (AML) and how a specific protein, MPP8, helps keep these elements in check; understanding this could help find new ways to treat AML for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | St. Jude Children's Research Hospital NIH-funded |
| Lab location | 1 site (Memphis, United States) |
| Project ID | NIH-11001993 on NIH RePORTER |
What this research studies
This research investigates the role of LINE-1 retrotransposons, a type of genetic element, in the development and progression of acute myeloid leukemia (AML). By utilizing advanced CRISPR technology, the study aims to identify how these elements contribute to genetic mutations and chromosomal changes in AML cells. The research focuses on a specific protein, MPP8, which is crucial for silencing these retrotransposons, and examines how its loss can lead to leukemia initiation and resistance to therapy. Patients may benefit from insights that could lead to new treatment strategies targeting these genetic mechanisms.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with acute myeloid leukemia who may benefit from new treatment approaches targeting genetic factors.
Not a fit: Patients with other types of leukemia or those without acute myeloid leukemia may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies that improve outcomes for patients with acute myeloid leukemia.
How similar studies have performed: Previous research has shown promising results in targeting genetic elements in cancer, suggesting that this approach could be effective.
Where this research is happening
Memphis, United States
- St. Jude Children's Research Hospital — Memphis, United States (Active)
Researchers
- Principal investigator: Xu, Jian — St. Jude Children's Research Hospital
- Study coordinator: Xu, Jian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.